Development of a Respirable, Sustained Release Microcarrier for 5-Fluorouracil I: In Vitro Assessment of Liposomes, Microspheres, and Lipid Coated Nanoparticles-Reference-Cited by-同舟云学术

Development of a Respirable, Sustained Release Microcarrier for 5-Fluorouracil I: In Vitro Assessment of Liposomes, Microspheres, and Lipid Coated Nanoparticles

Published:2006-05 Issue:5 Volume:95 Page:1114-1126
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Hitzman Cory J.,Elmquist William F.,Wattenberg Lee W.,Wiedmann Timothy S.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference35 articles.

1. Cancer facts and figures 2003,2003

2. The American College of Surgeons Commission on Cancer and the American Cancer Society ten-year survey of lung cancer treatment and survival in hospitals in the United States;Fry;Cancer,1999

3. Cancer of the lung;Vaporcian,2000

4. Fluorinated pyrimidines;Grem,1990

5. The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents;Tanaka;Curr Pharm Biotech,2000

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems;International Journal of Pharmaceutics;2024-09

2. Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation;Nanomedicine;2024-08-15

3. A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases;European Journal of Pharmaceutical Sciences;2024-04

4. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer;Pharmaceutics;2023-12-14

5. The state of the art in core–shell-type lipid–polymer hybrid nanocarriers and beyond;Polymer Bulletin;2023-08-21